POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (11.19.2021, 4:50pm CEST, WHO):   India 11,106    Brazil 11,977    United Kingdom 46,858    Russia 37,156    Turkey 22,234    France 19,840    Argentina 1,553    Germany 52,970    Spain 3,932    Columbia 2,257    Italy 10,645    Mexico 3,836    Ukraine 20,050    Poland 23,242    Philippines 1,297    Malaysia 6,380    Netherlands 23,680    Peru 1,370    Thailand 6,855    Czechia 13,374    Canada 2,448    Romania 3,076    Chile 2,611    Serbia 3,219    Sweden 1,210    Portugal 2,398    Vietnam 10,223    Kazakhstan 1,272    Austria 14,212    Hungary 11,289    Greece 7,276    Georgia 4,278    Bulgaria 2,785    Belarus 1,844    Slovakia 7,418    Azerbaijan 2,124    Croatia 7,270    Bolivia 1,119    Ireland 4,646    Lithuania 1,847    Denmark 4,013    South Korea 3,034    Slovenia 3,662    Latvia 1,221    Laos 1,401    China 31    New Zealand 200    Australia 1,302   

FDA got 127 reports of seizure related to e-cigarettes, severe lung injury cases in Minnesota

Christian Fernsby |
The FDA has posted additional reports the agency has received since April related to e-cigarette users experiencing seizures.

Article continues below



Topics: FDA    CIGARETTE   

These additional reports of events that occurred over the last 10 years do not necessarily indicate an increase in frequency or prevalence of such incidents.

In addition, some users reported other serious neurological symptoms such as fainting or tremors, which may or may not be related to seizures.

In total, including those posted in April, the agency has received 127 reports of seizure or other neurological symptoms that occurred between 2010 and 2019.

The Minnesota Department of Health (MDH) is encouraging Minnesota health care providers to be on alert for novel cases of severe lung disease potentially related to vaping and e-cigarette use among teens and young adults.

Children’s Minnesota has reported finding four cases of severe lung injury in the metro area potentially related to vaping. These cases are similar to lung disease cases recently reported in Wisconsin and Illinois, though it is too early to say whether they are connected.

In Minnesota, symptoms have resulted in hospitalizations lasting multiple weeks, with some patients being admitted to the intensive care unit. Product names are unknown.

Clinical presentation among Minnesota cases included shortness of breath, fever, cough, and vomiting and diarrhea.

Other symptoms reported by some patients included headache, dizziness, and chest pain.

After receiving reports from Children’s Thursday, MDH started working in partnership with Children’s to learn more about the cases.

Use of both nicotine and marijuana-based products were reported.

The state health department is also asking providers to look for similar cases and report them.

Clinicians should ask patients who present with pulmonary symptoms about tobacco and marijuana use, particularly vaping.

Clinicians should consult with pulmonologists and evaluate for infectious diseases when treating patients with pulmonary symptoms who report a history of vaping.


What to read next

Dramatic increase in e-cigarette use among youth in U.S.
FDA OKs first cancer drug by genetic type, not organ of origin
FDA Commissioner: Epidemic use of e-cigarettes among children